Expanding Testing Genemarkers has consistently expanded its portfolio with new assays such as in vitro melanin inhibition, blue light gene panels, microRNA panels, and protection/recovery testing for skin formulations. This indicates a growth trajectory in genomics-based testing services that can be cross-sold to cosmetic and dermatology clients seeking broader analytical capabilities.

Pharmacogenomics Network With active partnerships and expanded relationships through CPESN networks and Carymed, Genemarkers demonstrates a strong channel to pharmacy and clinical settings. This suggests sales opportunities in PGx testing collaborations, personalized skincare, and pharmacogenomics-informed product development.

Dermal Focus Genemarkers specializes in dermatology, skin-related research, and transdermal exposure models, positioning them as a preferred partner for cosmetic brands and consumer product developers seeking genomic insights for ingredient safety, efficacy, and skin biology endpoints.

Quality & Compliance CLIA-certified and CAP-accredited status signals high-quality, compliant laboratory services. This reliability can be leveraged to pursue larger trials, regulatory submissions, and partnerships with cosmetic/pharma companies requiring validated genomic data.

Tech-Driven Services A tech stack including next generation bioinformatics, computational modeling, and specialized gene expression panels indicates capacity to support complex data analysis for product development. This enables cross-sell to clients needing integrated wet-lab and data science solutions.